EDIT:NASDAQ
Editas Medicine Inc
US$2.57
arrow_upward
+0.78%(+0.020) 1D
US$2.57
0.00% (0.00)
bedtimeAfter hours
Closed: ኖቬም 6, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
US$2.55
High
US$2.63
Low
US$2.48
Mkt. cap
394.70 ሚ
Avg. vol.
2.33 ሚ
Volume
1.72 ሚ
52-wk high
US$3.94
52-wk low
US$1.66
EPS
-US$0.74
Beta
2.09
Shares outstanding
153.58 ሚ
No. of employees
87
Open
US$2.55
High
US$2.63
Low
US$2.48
Mkt. cap
394.70 ሚ
Avg. vol.
2.33 ሚ
Volume
1.72 ሚ
52-wk high
US$3.94
52-wk low
US$1.66
EPS
-US$0.74
Beta
2.09
Shares outstanding
153.58 ሚ
No. of employees
87
News stories
From web sources and news partners
Investing.com
·
ከ57 ደቂቃዎች በፊት
Wall St futures mixed amid AI spending concerns; inflation data awaited
FXLeaders
·
ከ12 ደቂቃዎች በፊት
Dow Futures Rise as Nasdaq Futures Fall on Microsoft-Oracle News
Yahoo Finance
·
ከ2 ሰዓቶች በፊት
Forget the High-Beta Hype: 5 ‘Sleep Well at Night’ Stocks to Buy Now
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedኖቬም 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com